Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials
Journal of the American College of Cardiology | 9 Feb 2018
AC Pinho-Gomes, L Azevedo, JM Ahn, SJ Park, TH Hamza, ME Farkouh, PW Serruys, M Milojevic, AP Kappetein, GW Stone, A Lamy, V Fuster and DP Taggart
Despite the well-established benefits of secondary cardiovascular prevention, the importance of concurrent medical therapy in clinical trials of coronary revascularization is often overlooked.
* Data courtesy of Altmetric.com